Lauren Dembeck, PhD, Author at Hematology Advisor
Lauren Dembeck, PhD

Lauren Dembeck, PhD

Contributing Writer https://www.hematologyadvisor.com
Lauren Dembeck is a freelance science and medical writer and a contributing author for the Haymarket Medical Network. She holds a BS in biology and a BA in foreign languages from West Virginia University and a PhD in genetics from North Carolina State University. Prior to freelance writing, Lauren was a postdoctoral researcher at the Okinawa Institute of Science and Technology in Japan, where she studied developmental neurobiology. You can find more of her writing at https://laurendembeck.com/.

All articles by Lauren Dembeck, PhD

Patients with lymphoma or myeloma completed were assessed prior to and 1 month after initiating chemotherapy for depressive symptoms.

Depressive Symptoms May Be Associated With Survival in Patients With Hematologic Malignancies

According to a study published in Psycho‐Oncology, patients with newly diagnosed malignant lymphoma or multiple myeloma who reported depressive symptoms prior to the start of chemotherapy had poorer survival compared with patients who were not initially depressed. The prospective analysis was conducted at the Nagoya City University Hospital in Japan. Researchers sought to investigate the…

Next post in Thrombotic Disorders